FI965292L - HIV:tä vastaan suunnattu kolmen aineen yhdistelmä - Google Patents
HIV:tä vastaan suunnattu kolmen aineen yhdistelmä Download PDFInfo
- Publication number
- FI965292L FI965292L FI965292A FI965292A FI965292L FI 965292 L FI965292 L FI 965292L FI 965292 A FI965292 A FI 965292A FI 965292 A FI965292 A FI 965292A FI 965292 L FI965292 L FI 965292L
- Authority
- FI
- Finland
- Prior art keywords
- combination
- against hiv
- agents against
- agents
- hiv
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP94201897 | 1994-07-01 | ||
| PCT/EP1995/002462 WO1996001110A2 (en) | 1994-07-01 | 1995-06-23 | Anti-hiv triple combination |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI965292A0 FI965292A0 (fi) | 1996-12-31 |
| FI965292A7 FI965292A7 (fi) | 1996-12-31 |
| FI965292L true FI965292L (fi) | 1996-12-31 |
Family
ID=8217000
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI965292A FI965292L (fi) | 1994-07-01 | 1995-06-23 | HIV:tä vastaan suunnattu kolmen aineen yhdistelmä |
Country Status (25)
| Country | Link |
|---|---|
| EP (1) | EP0768881B1 (cs) |
| JP (1) | JP2945481B2 (cs) |
| KR (1) | KR100218495B1 (cs) |
| CN (1) | CN1091599C (cs) |
| AP (1) | AP9600896A0 (cs) |
| AT (1) | ATE218867T1 (cs) |
| AU (1) | AU693911B2 (cs) |
| BG (1) | BG101175A (cs) |
| BR (1) | BR9508201A (cs) |
| CA (1) | CA2193489A1 (cs) |
| CZ (1) | CZ375596A3 (cs) |
| DE (1) | DE69527066T2 (cs) |
| EE (1) | EE9600180A (cs) |
| FI (1) | FI965292L (cs) |
| HU (1) | HUT77720A (cs) |
| IL (1) | IL114415A0 (cs) |
| MX (1) | MX9700044A (cs) |
| MY (1) | MY130597A (cs) |
| NO (1) | NO965556D0 (cs) |
| OA (1) | OA10341A (cs) |
| PL (1) | PL317891A1 (cs) |
| SK (1) | SK168196A3 (cs) |
| TW (1) | TW401303B (cs) |
| WO (1) | WO1996001110A2 (cs) |
| ZA (1) | ZA955471B (cs) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0942747A1 (en) * | 1996-08-26 | 1999-09-22 | Chiron Corporation | Postinfection human immunodeficiency virus (hiv) vaccination therapy |
| EP0872233A1 (en) * | 1997-04-14 | 1998-10-21 | Janssen Pharmaceutica N.V. | Antiretroviral compositions with improved bioavailability |
| DE60025837T2 (de) | 1999-09-24 | 2006-11-02 | Janssen Pharmaceutica N.V. | Antivirale feste dispersionen |
| MY169670A (en) | 2003-09-03 | 2019-05-08 | Tibotec Pharm Ltd | Combinations of a pyrimidine containing nnrti with rt inhibitors |
| US9044509B2 (en) | 2006-02-03 | 2015-06-02 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Inhibition of HIV infection through chemoprophylaxis |
| AR065720A1 (es) | 2007-03-14 | 2009-06-24 | Tibotec Pharm Ltd | Polvos para reconstitucion que comprenden rilpivirina dispersos en ciertos polimeros. uso. proceso. |
| US8481554B2 (en) | 2009-05-27 | 2013-07-09 | Hetero Research Foundation | Solid oral dosage forms of lamivudine |
| US20210128554A1 (en) * | 2016-12-23 | 2021-05-06 | Temple University - Of The Commonwealth System Of Higher Education | Anti-flaviviridae activity of anti-retroviral non-nucleoside (nnrtis) and nucleoside reverse transcriptase inhibitors (nnrtis) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69206876T3 (de) * | 1991-05-16 | 2004-08-12 | Glaxo Group Ltd., Greenford | Nukleosidanalogen enthaltende Antiviren-Zubereitungen |
-
1994
- 1994-05-25 TW TW084105260A patent/TW401303B/zh active
-
1995
- 1995-06-23 CN CN95193943A patent/CN1091599C/zh not_active Expired - Fee Related
- 1995-06-23 HU HU9603627A patent/HUT77720A/hu unknown
- 1995-06-23 EE EE9600180A patent/EE9600180A/xx unknown
- 1995-06-23 MX MX9700044A patent/MX9700044A/es unknown
- 1995-06-23 CA CA002193489A patent/CA2193489A1/en not_active Abandoned
- 1995-06-23 SK SK1681-96A patent/SK168196A3/sk unknown
- 1995-06-23 CZ CZ963755A patent/CZ375596A3/cs unknown
- 1995-06-23 JP JP8503654A patent/JP2945481B2/ja not_active Expired - Fee Related
- 1995-06-23 AU AU29248/95A patent/AU693911B2/en not_active Ceased
- 1995-06-23 AP APAP/P/1996/000896A patent/AP9600896A0/en unknown
- 1995-06-23 BR BR9508201A patent/BR9508201A/pt not_active Application Discontinuation
- 1995-06-23 FI FI965292A patent/FI965292L/fi not_active Application Discontinuation
- 1995-06-23 AT AT95924930T patent/ATE218867T1/de not_active IP Right Cessation
- 1995-06-23 WO PCT/EP1995/002462 patent/WO1996001110A2/en not_active Ceased
- 1995-06-23 PL PL95317891A patent/PL317891A1/xx unknown
- 1995-06-23 EP EP95924930A patent/EP0768881B1/en not_active Expired - Lifetime
- 1995-06-23 DE DE69527066T patent/DE69527066T2/de not_active Expired - Fee Related
- 1995-06-30 ZA ZA955471A patent/ZA955471B/xx unknown
- 1995-06-30 IL IL11441595A patent/IL114415A0/xx unknown
- 1995-06-30 MY MYPI95001822A patent/MY130597A/en unknown
-
1996
- 1996-12-23 NO NO965556A patent/NO965556D0/no unknown
- 1996-12-27 KR KR1019960707474A patent/KR100218495B1/ko not_active Expired - Fee Related
- 1996-12-31 OA OA60946A patent/OA10341A/en unknown
-
1997
- 1997-01-27 BG BG101175A patent/BG101175A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SK168196A3 (en) | 1997-05-07 |
| IL114415A0 (en) | 1995-10-31 |
| TW401303B (en) | 2000-08-11 |
| ZA955471B (en) | 1996-12-30 |
| AU693911B2 (en) | 1998-07-09 |
| ATE218867T1 (de) | 2002-06-15 |
| FI965292A0 (fi) | 1996-12-31 |
| HU9603627D0 (en) | 1997-02-28 |
| EP0768881B1 (en) | 2002-06-12 |
| JP2945481B2 (ja) | 1999-09-06 |
| NO965556L (no) | 1996-12-23 |
| BG101175A (bg) | 1997-08-29 |
| HUT77720A (hu) | 1998-07-28 |
| NO965556D0 (no) | 1996-12-23 |
| FI965292A7 (fi) | 1996-12-31 |
| DE69527066D1 (de) | 2002-07-18 |
| PL317891A1 (en) | 1997-04-28 |
| CA2193489A1 (en) | 1996-01-18 |
| JPH09507858A (ja) | 1997-08-12 |
| EE9600180A (et) | 1997-06-16 |
| DE69527066T2 (de) | 2003-02-13 |
| WO1996001110A3 (en) | 1996-02-22 |
| WO1996001110A2 (en) | 1996-01-18 |
| BR9508201A (pt) | 1997-11-11 |
| EP0768881A2 (en) | 1997-04-23 |
| OA10341A (en) | 1997-10-07 |
| CZ375596A3 (en) | 1997-04-16 |
| KR100218495B1 (en) | 1999-09-01 |
| MY130597A (en) | 2007-07-31 |
| MX9700044A (es) | 1997-04-30 |
| AP9600896A0 (en) | 1997-01-31 |
| AU2924895A (en) | 1996-01-25 |
| CN1151697A (zh) | 1997-06-11 |
| CN1091599C (zh) | 2002-10-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT885887E (pt) | Inibidores de sulfonamida de aspartil-protease de hiv | |
| EP0801656A4 (en) | OBTAINING T CYTOTOXIC LYMPHOCYTE REACTIONS | |
| DE69534990D1 (de) | Kontrastmittel | |
| DE69621528D1 (de) | Anti-inflamatorische agenzien | |
| FI963451A7 (fi) | Antitromboottisia aineita | |
| DE69423125D1 (de) | Meteologischer Arbeitsplatz | |
| PT828506E (pt) | Agentes endoparasiticidas | |
| FI101957B1 (fi) | Nosturi | |
| DE69315205D1 (de) | Bedienungsarbeitsplatz | |
| FI946105A7 (fi) | Hypokolesterolemisia aineita | |
| FI953742L (fi) | Hapettavat aineet | |
| MA23356A1 (fr) | Agents anti-viraux | |
| NO970158D0 (no) | Difluorstaton-antivirale midler | |
| MA23202A1 (fr) | Agents d'arylation | |
| NO965556D0 (no) | Trippelkombinasjon mot HIV | |
| FI944004A0 (fi) | Bettkonstruktion foer kross | |
| FI965196A7 (fi) | HIV-infektion yhdistelmähoito | |
| DE59504996D1 (de) | Arbeitsplatz | |
| DK60694A (da) | Liftophængt redskab | |
| ZA954426B (en) | Post-exposure prevention of HIV | |
| KR940018972U (ko) | 위생 발판 | |
| FI945565A0 (fi) | Käsiohjain | |
| KR960015011U (ko) | 가대 | |
| KR960007895U (ko) | 작업용 발판 | |
| FI970565L (fi) | HIV-proteaasia inhiboiva yhdistelmä |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application lapsed |